NeuroFront Therapeutics
Investor profile
Venture capital
NeuroFront Therapeutics has backed 1 European tech company across 1 funding round in 2022, joining rounds totalling €127M. Most active in Healthtech. Data as of Nov 2026.
Deals
1
distinct rounds
Companies
1
backed
Active span
2022
1 yr
Total round €
€127M
sum of rounds joined
Deals by year
distinct rounds / yearNeuroFront Therapeutics — deals by year — interactive chart.
Data table
| NeuroFront Therapeutics — deals by year | |
|---|---|
| 2022 | 1 |
Top sectors
by dealsNeuroFront Therapeutics — top sectors — interactive chart.
Data table
| NeuroFront Therapeutics — top sectors | |
|---|---|
| Healthtech | 1 |
Stages
by dealsNeuroFront Therapeutics — stages — interactive chart.
Data table
| NeuroFront Therapeutics — stages | |
|---|---|
| Other | 1 |
Countries
by dealsNeuroFront Therapeutics — countries — interactive chart.
Data table
| NeuroFront Therapeutics — countries | |
|---|---|
| Switzerland | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared roundsNo co-investors found.
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Novaremed | Switzerland | 1 | €127M |